Cyclizine - Isotope Labelled Standards
References
FAQ's
References
- Improvements in and relating to the preparation of piperazine compounds, GB655839A, Aug 1, 1951, Burroughs Wellcome & Co. (U.S.A.) Inc., Wellcome Foundation Ltd. (https://www.lens.org/lens/search/patent/list?q=GB655839)
- Land, G.; Dean, K.; Bye, A., Determination of cyclizine and norcyclizine in plasma and urine using gas-liquid chromatography with nitrogen selective detection, Journal of Chromatography, Biomedical Applications, Volume: 222, Issue: 1, Pages: 135-40, 1981 DOI: (10.1016/s0378-4347(00)81043-9)
Frequently Asked Questions
2. How do we detect the Cyclizine impurities in the drug substance?
UPLC can detect the Cyclizine impurities in the drug substance.
3. Which analytical method detects the presence of Cyclizine degradation products in the drug product?
RP-HPLC method is the analytical method that determines the presence of Cyclizine degradation products in the drug product.
4. How do the Cyclizine degradation products form?
Cyclizine degradation products form under acid, alkaline, oxidative, heat, and light conditions.
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.